|
CRP,human C-Reactive Protein, Human Quantitation kit
The Helica C-reactive protein assay is intended for the detection and quantification of human C-reactive protein (CRP) in human serum. C-reactive protein is an acute-phase protein produced by the liver in conditions of inflammation, bacterial infection, or tissue trauma. Quantification of CRP is useful in determining inflammatory conditions difficult to diagnose and to monitor the patients¡¯ response to treatment.
Detection Range
C-Reactive Protein, Human...............0.12 - 10 ng/mL
MATERIALS SUPPLIEDThe Helica¢â C-Reactive Protein kit supplies sufficient materials for 96 determinations. 1. CRP ELISA microplate 2. Conjugate (100x) 0.13 mL 3. CRP Standard, 1.0ug/mL (100X), 0.13 mL 4. Wash Buffer, 1 packet 5. TMB Substrate, 12 mL 6. Stop Solution, 12 mL
References
1. Buduneli, E. et. al. Systemic Low-Dose Doxycycline and Alendronate Administration and Serum Interleukin-1Beta, Osteocalcin, and C-Reactive Protein Levels in Rats. Journal of Periodontology 2005;76:1927-1933 2. Cai, X. et.al. The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis. Arch. Pharmacol. 2006; 373:140-147 3. Chen, K. et. Induction of Leptin Resistance Through Direct Interaction of C-reactive Protein with Leptin. Nature Medicine 2006;12:425 - 432 (Human CRP) 4. Cho W. C. et.al. Differential Expression of Proteins in Kidney, Eye, Aorta, and Serum of Diabetic and Non- diabetic Rats. J. Cell. Biochem. 2006; 99: 256 - 268 5. Kalani, R., et.al. Effects of Caloric Restriction and Exercise on Age-Related, Chronic Inflammation Assessed by C-Reactive Protein and Interleukin-6Effects of Caloric Restriction and Exercise on Age-Related, Chronic Inflammation Assessed by C-Reactive Protein and Interleukin-6. Journal of Gerontology: 2006; 61A: 3:211-217 6. Ling, S. and F. Jabali. Effect of Early Phase Adjuvant Arthritis on Hepatic P450 Enzymes and Pharmacokinetics of Verapamil: An Alternative Approach to the Use of An Animal Model for Inflammation for Pharmacokinetic Studies. Drug Metabolism and Disposition 2005; 33:579-586 7. Ortiz, R. et. al. Urinary C-Reactive Protein Excretion Increases in Angiotensin II-Dependent Hypertensive Rats. FASEB Journal 2006; 20: 470.16 8. Shagdarsuren, E. et al. Complement Activation in Angiotensin II-Induced Organ Damage. Circ Res. 2005; 97:716-724 |